Aguilar, Jesus Ledesma

Court of Criminal Appeals of Texas·Decided May 22, 2006·No. WR-36,142-03·Published

Opinion







IN THE COURT OF CRIMINAL APPEALS

OF TEXAS



NO. WR-36,142-03
EX PARTE JESUS LEDESMA AGUILAR, Applicant


ON APPLICATION FOR WRIT OF HABEAS CORPUS

IN CAUSE NO. 95-CR-1088 FROM THE

107TH DISTRICT COURT OF CAMERON COUNTY

Cochran, J., filed a concurring statement, in which Hervey, J., joined.

CONCURRING STATEMENT



I respectfully concur in the Court's action dismissing the subsequent application for a writ of habeas corpus.

Regardless of the appropriate procedure that might apply to claims of this nature, applicant has failed to make a prima facie showing that the lethal injection protocol used by the Texas Department of Criminal Justice (TDCJ) creates such a risk of unnecessary pain or suffering that its use must be declared unconstitutional. He has failed to show any reasonable likelihood of success on either the law or the facts.

As was true in Ex parte O'Brien, (1) applicant in this case has failed to show that any of the 37 states that currently use lethal injection have found that it causes unconstitutionally wanton and unnecessary pain:

Of the thirty-eight states that presently permit capital punishment, approximately thirty-seven of them have adopted lethal injection as the primary means of execution. Almost every single one of those states uses the same three chemicals as TDCJ. Moreover, I am unable to find any court that has held that lethal injection in general, or a specific lethal-injection protocol in particular, violates the Eighth Amendment. (2)



Applicant thus fails to provide a legal basis for his constitutional claim.

Turning to the factual basis, applicant has provided this court with a number of exhibits and anecdotal examples which purport to demonstrate a scientific basis for his claim. One of applicant's exhibits states, "[w]hen analyzing a particular method of execution or the implementation thereof, it is appropriate to focus 'on the objective evidence of the pain involved.'" (3) Applicant's exhibits and examples, however, do not set out any objective evidence of a reasonable risk of unnecessary or wanton pain in the TDCJ protocol.

Applicant's primary scientific exhibit is a research letter (4) entitled "Inadequate Anaesthesia in Lethal Injection for Execution," that appeared in the British medical journal, The Lancet, in April, 2005. This letter/article has been noted by several different courts that have rejected claims similar to applicant's. (5)

There are serious problems with this letter. First, it is published under the heading "Research Letters." Thus, it is akin to a Letter to the Editor about an ongoing research project and makes no claim to be a peer-reviewed scientific study. Second, it states that the idea for the letter, the protocol information, and the data all came from "J.P. Shelden" whom the article notes is "an attorney who represents inmates sentenced to death." (6) An article conceived by and based upon data supplied by an attorney who sole scientific credential is that he represents death row inmates is hardly a mark of scientific objectivity. Third, the suggested conclusion is so extraordinary that it challenges simple logic.

The authors posit that post-mortem concentrations of thiopental (also known as sodium pentothal) in 43 out of 49 executed inmates were lower than that required for a surgically sound level of unconsciousness. They also posit that, based upon their post-mortem data, 21 out of the 49 inmates would have been conscious at the time the final drug was administered. That is, over 85% of the time the fatal dose of sodium thiopental did not cause even a deep level of unconsciousness, and, over 40% of the time, it was totally ineffective. Either the use of sodium pentothal as an anaesthetic in the lethal injection process is an utter fraud and delusion, or this study is fundamentally flawed.

Because this habeas corpus application, like so many throughout the nation, is brought at the eleventh hour, the State has not had the opportunity to respond with its own scientific information. To a layman, however, one explanation for the peculiar results in this study is that the authors may not be comparing apples to apples. The article suggests that it compared the levels of sodium thiopental in the blood of those undergoing surgery with the post-mortem levels of sodium thiopental found during same-day or next-day autopsies of executed inmates. This assumes that the level of sodium thiopental in the body remains constant both during its surgical use as an anaesthetic and as a post-mortem residue. But if part of the value of sodium thiopental is that it is ultra fast-acting and then wears off very rapidly, a layman might well conclude that the fact that little sodium thiopental residue is found during post-mortem autopsies is because it had worn off and dissipated. (7) Absent scientific confirmation by studies compiled and conducted by objective scientists, this study raises questions but provides no answers.

Applicant also relies upon an affidavit submitted by Dr. Mark Heath in a California federal district court. (8) Dr. Heath has testified in numerous cases claiming that the lethal injection protocol in various states creates a risk of unnecessary pain and suffering. (9) Dr. Heath states that "[f]ive grams of sodium thiopental is a massive, and potentially lethal, dose," (10) and "[w]hen successfully delivered into the circulation in sufficient quantities, sodium thiopental causes sufficient depression of the nervous system to permit excruciatingly painful procedures to be performed without causing discomfort or distress." (11) That is, if the sodium thiopental is properly administered, the process works without pain. But Dr. Heath notes that potential problems exist in the delivery of that anaesthetic during the execution process:

* Errors in preparation; the person who mixes the powdered sodium thiopental might not mix the right amount into the solution;

* Errors in labeling; the person who labels the different lethal injection syringes might mislabel them;

* Errors in selecting the correct syringe: the person injecting the drugs might use the wrong syringe at the wrong time;

* Errors in correctly injecting the drug into the intravenous line; the person injecting the drugs into the IV might inject the drug into the IV fluid bag instead of the inmate;

* The IV tubing might leak;

* Incorrect insertion of the catheter; the person putting the catheter into the inmate might not insert it into a vein, allowing the drug to infiltrate the tissues;

* Migration of the catheter; the catheter could move out of the vein during the process;

* Perforation or rupture or leakage of the vein; the catheter might stay in place, but the inmate's vein might burst and cause infiltration of the drugs into the surrounding tissue;

Free access — add to your briefcase to read the full text and ask questions with AI

Aguilar, Jesus Ledesma, (Tex. 2006).

Aguilar, Jesus Ledesma (Aguilar, Jesus Ledesma) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Arthur D. Rutherford v. James v. Crosby, Jr.
438 F.3d 1087 (Eleventh Circuit, 2006)
Bieghler v. State
839 N.E.2d 691 (Indiana Supreme Court, 2005)
Ex Parte O'Brien
190 S.W.3d 677 (Court of Criminal Appeals of Texas, 2006)
Hill v. State
921 So. 2d 579 (Supreme Court of Florida, 2006)
Morales v. Hickman
415 F. Supp. 2d 1037 (N.D. California, 2006)
Fierro v. Gomez
77 F.3d 301 (Ninth Circuit, 1996)
Brown v. Crawford
408 F.3d 1027 (Eighth Circuit, 2005)